Pharmaceutical News

RSS

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis’ PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.

3 May 2017

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

The Biologics Prescribers Collaborative (BPC), a project of the Alliance for Patient Access, released a new white paper, “The State of Biosimilars Policy.” The paper is released in conjunction with a congressional briefing on Capitol Hill where experts will discuss the current biosimilars policy framework and its impact on prescribing, reimbursement and use.

3 May 2017

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics® and personalized molecular medicine®, today announces the premarket approval of LeukoStrat® CDx FLT3 Mutation Assay.

3 May 2017

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire plc and Parion Sciences, Inc. have announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investigational epithelial sodium channel (ENaC) inhibitor for the potential treatment of dry eye disease in adults, with the opportunity for Parion to co-fund.

3 May 2017

Pharma supply chain "needs to get out of its silos"

This was the message from Alan Kennedy of TEAM-UP speaking at the 2017 LogiPharma Conference in Montreux on April 25th - 27th 2017. Kennedy said that the pharma supply chain needs to prioritise getting out of its silos and start working in unison to push and embrace fundamental structural reform.

3 May 2017

Molecular drug imaging likely to benefit children with brain tumors

Brain cancers are difficult to treat, and it can be hard to predict whether a therapy will be effective. When the patient is a child, it's even more important to predict the potential effectiveness of a drug before beginning treatment.

3 May 2017

Survey shows nearly 90% of patients on warfarin would like to self-monitor

Roche Diagnostics UK and Ireland launches the next generation of INR patient self-monitoring meter for people on warfarin anticoagulant therapy.

3 May 2017

PCSK9 Inhibitors: Highlights barriers to new, breakthrough cholesterol-lowering drugs

Today the Partnership to Advance Cardiovascular Health released a new web video, “PCSK9 Inhibitors: Access Barriers Affect Real People” The video, featuring patient testimonials, explores access issues to new, breakthrough cholesterol-lowering drugs known as PCSK9 inhibitors.

3 May 2017

NIST chemists publish new data on important compound’s thermodynamic properties

Amantadine hydrochloride may be the most common medication you've never heard of. This compound has been around for decades as the basis for antiviral and other medications, from flu therapy to treatments for brain disorders such as Parkinson's disease and the fatigue associated with multiple sclerosis.

2 May 2017

Infantile spasms and multiple sclerosis relapse data presented at AAN

Mallinckrodt plc, a specialty pharmaceutical company, announced new results from two company-sponsored studies: one study on use of H.P. Acthar® Gel (repository corticotropin injection) in patients with infantile spasms (IS) and a second study on the economic burden of moderate-to-severe multiple sclerosis (MS) relapse.

2 May 2017

Making doctors check patients' drug history could be simple way to reduce opioid epidemic

There's a simple way to reduce the opioid epidemic gripping the country, according to new Cornell University research: Make doctors check their patients' previous prescriptions.

2 May 2017

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

Surgery and radiation remove, kill, or damage cancer cells in a certain area. But chemotherapy -- which uses medicines or drugs to treat cancer -- can work throughout the whole body, killing cancer cells that have spread far from the original tumor.

2 May 2017

New chiral molecular sieves may lead to production of better drugs

An international team of researchers, led by Mark E. Davis at Caltech, has succeeded in making the first chiral molecular sieves. This discovery opens new areas of investigation in both chemistry and biology, and has broad implications for pharmaceutical companies and other specialized chemical manufacturers.

2 May 2017

Adjusting dose of psychiatric drugs could reduce fall risk among elderly people

Simply adjusting the dose of an older adult's psychiatric medication could reduce their risk of falling, a new University of Michigan study suggests.

2 May 2017

Powerful pain medicine may help reduce vision damage of glaucoma

The tip of our optic nerve is typically the first place injured by glaucoma. Now researchers want to know if the powerful pain medicine (+)-pentazocine can help avoid the damage.

2 May 2017

Low-cost drug for severe bleeding could save lives of mothers after childbirth

An inexpensive and widely available drug could save the lives of one in three mothers who would otherwise bleed to death after childbirth, according to a major study published in The Lancet. The global trial of 20,000 women found that death due to bleeding was reduced by 31% if the treatment was given within three hours.

29 Apr 2017

Pharmaceutical News

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Pharma supply chain "needs to get out of its silos"

Molecular drug imaging likely to benefit children with brain tumors

Survey shows nearly 90% of patients on warfarin would like to self-monitor

PCSK9 Inhibitors: Highlights barriers to new, breakthrough cholesterol-lowering drugs

NIST chemists publish new data on important compound’s thermodynamic properties

Infantile spasms and multiple sclerosis relapse data presented at AAN

Making doctors check patients' drug history could be simple way to reduce opioid epidemic

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

New chiral molecular sieves may lead to production of better drugs

Adjusting dose of psychiatric drugs could reduce fall risk among elderly people

Powerful pain medicine may help reduce vision damage of glaucoma

Low-cost drug for severe bleeding could save lives of mothers after childbirth

China creates new kinase-based whole-cell screening library for high-throughput drug assay

Study highlights importance of educating family members on opioid overdoses and naloxone use

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Cheaper topical steroids could lead to potential health care and out-of-pocket savings

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News